Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 06:49:20 +0200Fri, 12 Jul 2024 15:33:00 +0200Human medicines European public assessment report (EPAR): Remsima, infliximab, Date of authorisation: 10/09/2013, Revision: 40, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/remsimaHuman medicines European public assessment report (EPAR): Remsima, infliximab, Date of authorisation: 10/09/2013, Revision: 40, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/remsimaFri, 12 Jul 2024 15:33:00 +0200Human medicineRemsima : EPAR - Public assessment reporthttps://www.ema.europa.eu/system/files/documents/assessment-report/h-2576-par_en.pdfRemsima : EPAR - Public assessment reporthttps://www.ema.europa.eu/system/files/documents/assessment-report/h-2576-par_en.pdfFri, 04 Oct 2013 17:00:00 +0200Human medicine